Frank Rimerman Advisors LLC Purchases 1,947 Shares of Colgate-Palmolive Company $CL

Frank Rimerman Advisors LLC increased its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 29.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,462 shares of the company’s stock after buying an additional 1,947 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Colgate-Palmolive were worth $769,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Cidel Asset Management Inc. increased its stake in shares of Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after buying an additional 39,413 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 18.6% in the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after acquiring an additional 4,738 shares in the last quarter. Welch Group LLC increased its position in Colgate-Palmolive by 1.5% during the 2nd quarter. Welch Group LLC now owns 665,041 shares of the company’s stock valued at $60,452,000 after purchasing an additional 9,689 shares during the period. Arista Wealth Management LLC bought a new position in Colgate-Palmolive in the 2nd quarter worth $571,000. Finally, Mraz Amerine & Associates Inc. purchased a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $300,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CL shares. Bank of America decreased their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Citigroup reduced their target price on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. UBS Group lowered their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a research note on Friday, October 10th. Finally, Barclays lowered their price objective on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $89.87.

Get Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 1.1%

CL stock opened at $78.47 on Thursday. The business has a 50 day moving average of $78.88 and a 200 day moving average of $84.95. The firm has a market cap of $63.25 billion, a PE ratio of 22.04, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 earnings per share. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 17th were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.